Washington University: Siteman Cancer Center

St Louis, Missouri 63110-1010

3 studies enrolling now · 30 studies all time

What they study most

Acute Myeloid Leukemia, Advanced Malignancies, Advanced Solid Tumor, Advanced or Metastatic Solid Tumors, Anaplastic Thyroid Cancer, Biliary Tract Cancer, Bladder Cancer, Breast Cancer, CRC (Colorectal Cancer), Carcinoma, Castration-resistant Prostate Cancer, Chronic Myeloproliferative Disorders

Studies at this site

• A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer — Recruiting now
• A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma — Recruiting now
• A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors — Recruiting now
• Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor Therapy — Recruiting now
• A Phase 1 Study of LNCB74 in Advanced Solid Tumors — Recruiting now
• A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy — Running, not enrolling
• Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis — Running, not enrolling
• pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer — Running, not enrolling
• Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLC — Running, not enrolling
• Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS — Running, not enrolling
• Study of Inlexisertib (DCC-3116) in Participants With RAS/MAPK Pathway Mutant Solid Tumors — Stopped early
• A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies — Completed
• Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors — Running, not enrolling
• Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies — Completed
• Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized With NFKB2 Rearrangement — Completed
• Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects — Completed
• EPI-7386 in Combination with Enzalutamide Compared with Enzalutamide Alone in Subjects with MCRPC — Stopped early
• Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer — Completed
• A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomide — Stopped early
• Testing the PD-1 Inhibitor Pembrolizumab as Maintenance Therapy After Initial Chemotherapy in Metastatic Bladder Cancer — Completed
• A Phase 1 Study of AMV564 in Patients With Intermediate or High-Risk Myelodysplastic Syndromes — Completed
• Evaluation of t-RFA and RF-TVA Prior to/Following Radiation Therapy to Treat Painful Metastatic Vertebral Body Tumor(s) — Stopped early
• High Dose Vitamin D vs Standard Dose Vitamin D Study — Stopped early
• A Phase 1/2 Study of CS7017, an Oral PPARγ Agonist, in Combination With Paclitaxel — Stopped early
• Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) — Completed
• A Study to Determine the Efficacy and Safety of Lenalidomide in Patients With Mantle Cell NHL Who Have Relapsed or Progressed After Treatment With Bortezomib or Are Refractory to Bortezomib. The "EMERGE" Trial — Completed
• Hormone Therapy in Treating Patients With Prostate Cancer — Completed
• A Study of ONTAK in Patients With Relapsed or Refractory, B-Cell Non Hodgkin's Lymphoma — Completed
• Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy — NO_LONGER_AVAILABLE
• Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis — Completed